NASDAQ · ACHC
Healthcare · Medical - Care Facilities
$27.38
Up+$0.84 (+3.07%)
Updated Sep 16, 2026, 4:30 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ACHC closed at $27.38 after 20 trading sessions, down 0.29% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $27.94 | $28.03 | $26.97 | $27.38 | 1.19M |
| Sep 14, 2026 | $28.15 | $29.40 | $27.982 | $28.00 | 1.08M |
| Sep 11, 2026 | $28.96 | $29.26 | $28.23 | $28.36 | 653.21K |
| Sep 10, 2026 | $27.86 | $29.80 | $27.82 | $28.53 | 1.09M |
| Sep 9, 2026 | $27.42 | $28.75 | $26.85 | $28.19 | 1.72M |
| Sep 8, 2026 | $27.71 | $28.45 | $27.445 | $27.50 | 1.32M |
| Sep 4, 2026 | $28.24 | $28.765 | $27.81 | $28.13 | 835.04K |
| Sep 3, 2026 | $27.73 | $28.39 | $27.335 | $28.38 | 1.15M |
| Sep 2, 2026 | $28.19 | $28.59 | $27.50 | $27.75 | 1.14M |
| Sep 1, 2026 | $27.79 | $28.72 | $27.65 | $28.25 | 1.45M |
| Aug 31, 2026 | $28.27 | $28.545 | $27.49 | $27.56 | 2.08M |
| Aug 28, 2026 | $30.15 | $30.35 | $28.38 | $28.55 | 1.23M |
| Aug 27, 2026 | $30.14 | $30.55 | $29.39 | $30.22 | 1.32M |
| Aug 26, 2026 | $30.15 | $32.865 | $30.01 | $30.58 | 2.03M |
| Aug 25, 2026 | $28.88 | $29.915 | $28.58 | $29.87 | 1.91M |
| Aug 24, 2026 | $27.90 | $28.95 | $27.75 | $28.72 | 1.44M |
| Aug 21, 2026 | $27.17 | $27.84 | $26.62 | $27.82 | 1.11M |
| Aug 20, 2026 | $27.00 | $27.82 | $26.73 | $26.97 | 1.25M |
| Aug 19, 2026 | $27.77 | $29.25 | $27.11 | $27.36 | 2.24M |
| Aug 18, 2026 | $29.68 | $30.23 | $27.43 | $27.46 | 3.92M |
The latest Smart Investors Daily articles mentioning ACHC.
ACHC research
Company profile and research snapshot.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Guggenheim | Buy | — |
| Jul 30, 2026 | Barclays | Equal-Weight | — |
| Jul 20, 2026 | Guggenheim | Buy | — |
| Jul 14, 2026 | TD Cowen | Buy | — |
| Jul 14, 2026 | Keybanc | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 9, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 25.7% over the past six months while the S&P 500 was up 13.6%.
Yahoo · Sep 9, 2026
FRANKLIN, Tenn., September 09, 2026--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference on September 14th.
SeekingAlpha · Aug 24, 2026
LifeStance Health Group, Inc. stock is up 120% with revenue growth and better profitability. Click for this LFST earnings update.
SeekingAlpha · Aug 23, 2026
Acadia Healthcare's revenue continues to climb, but profitability is pressured by rising labor costs and a tight labor market. Read why ACHC stock is a soft Buy.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ACHC.
